LRP6 and neoplasm: In an oncogenic context, s2R/TMEM97 is implicated in the Wnt/beta-catenin pathway and upregulates low-density lipoprotein receptor related protein 6 (LRP6) phosphorylation that ultimately results in tumor growth (Pai et al., 2017).